State Street Corp Trims Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

State Street Corp cut its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,464,881 shares of the medical instruments supplier’s stock after selling 55,623 shares during the period. State Street Corp owned 3.25% of DENTSPLY SIRONA worth $175,967,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of XRAY. Quantinno Capital Management LP lifted its stake in shares of DENTSPLY SIRONA by 276.5% in the 3rd quarter. Quantinno Capital Management LP now owns 116,808 shares of the medical instruments supplier’s stock valued at $3,161,000 after purchasing an additional 85,787 shares during the period. Quarry LP raised its holdings in DENTSPLY SIRONA by 455.0% in the third quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock worth $82,000 after purchasing an additional 2,489 shares in the last quarter. Invenomic Capital Management LP purchased a new position in DENTSPLY SIRONA during the third quarter valued at $23,724,000. Paloma Partners Management Co bought a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $402,000. Finally, Edgestream Partners L.P. purchased a new stake in shares of DENTSPLY SIRONA in the 3rd quarter worth about $3,990,000. 95.70% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on XRAY shares. UBS Group lowered their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Needham & Company LLC lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Finally, Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Eight investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $28.40.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $20.01 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market cap of $3.98 billion, a price-to-earnings ratio of -9.67, a price-to-earnings-growth ratio of 1.92 and a beta of 0.96. The business has a 50-day simple moving average of $21.39 and a two-hundred day simple moving average of $24.26. DENTSPLY SIRONA Inc. has a fifty-two week low of $17.21 and a fifty-two week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same period in the previous year, the company earned $0.49 earnings per share. The firm’s quarterly revenue was up .4% on a year-over-year basis. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.